Immutep: Invests nearly $30M for ongoing clinical trials
Biotech company Immutep (IMM) has tapped institutional investors for a neat $29.6 million to fund its cancer and autoimmune diseases treatment trials
The...
© 2026 FintechInshorts. All Rights Reserved.

